Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1429-1442

  Arnett Mansfield, Rebecca L ^a,c   DeFazio, Anna ^a,b   Mote, Patricia A ^a   Clarke, Christine L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B;

ARTICLE; CELL PROLIFERATION; COHORT ANALYSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; GENE CONTROL; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MENSTRUAL CYCLE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; COHORT STUDIES; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; RECEPTORS, PROGESTERONE;

FALLOPIA;

EID: 1642344635     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031111     Document Type: Article

References (69)

1. Graham JD, Clarke CL 1997 Physiological action of progesterone in target tissues. Endocr Rev 18:502-519
2. Rose PG 1996 Endometrial carcinoma. N Engl J Med 335:640-649
3. Shoff SM, Newcomb PA 1998 Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 148:234-240
4. Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, Schwartz PE, O'Connor T, White C 1982 A case-control study of cancer of the endometrium. Am J Epidemiol 116:333-342
5. Elwood M, Cole P, Rothman KJ, Kaplan SD 1977 Epidemiology of endometrial cancer. J Natl Cancer Inst 59:1055-1060
6. Salvesen HB, Akslen LA, Albrektsen G, Iversen OE 1998 Poorer survival of nulliparous women with endometrial carcinoma. Cancer 82:1328-1333
7. Lentz SS 1998 Endocrine therapy of endometrial cancer. Cancer Treat Res 94:89-106
8. Marsden DE, Hacker NF 2001 Optimal management of endometrial hyperplasia. Best Pract Res Clin Obstet Gynaecol 15:393-405
9. Beresford SAA, Weiss NS, Voigt LF, McKnight B 1997 Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 349:458-461
10. CancerNet NCI 2003 Endometrial cancer for the health professionals. NCI: Physicians Data Query Data Base (PDQ). Endometrial Cancer (PDQ): Treatment. Available at: http://wwwncinihgov/cancerinfo/pdq/treatment/endometrial/ healthprofessional/
11. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-related promoters generate transcripts encoding the two functionally different human progesterone receptor isoforms A and B. EMBO J 9:1603-1614
12. Graham JD, Clarke CL 2002 Expression and transcriptional activity of PRA and PRB in mammalian cells. Breast Cancer Res 4:187-190
13. Mote PA, Balleine RL, McGowan EM, Clarke CL 1999 Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 84:2963-2971
14. Arnett-Mansfield RL, deFazio A, Wain GV, Jaworski RC, Byth K, Mote PA, Clarke CL 2001 Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 61:4576-4582
15. Schrader WT, O'Malley BW 1972 Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. J Biol Chem 247:51-59
16. Loosfelt H, Atger M, Misrahi M, Guiochon-Mantel A, Meriel C, Logeat F, Benarous R, Milgrom E 1986 Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA. Proc Natl Acad Sci USA 83:9045-9049
17. 3H]R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar. Endocrinology 120:1449-1456
18. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL 1995 Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 55:5063-5068
19. Htun H, Holth LT, Walker D, Davie JR, Hager GL 1999 Direct visualization of the human estrogen receptor aα reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10:471-486
20. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA 2000 Subnuclear trafficking of estrogen receptor-α and steroid receptor coactivator-1. Mol Endocrinol 14:518-534
21. Tomura A, Goto K, Morinaga H, Nomura M, Okabe T, Yanase T, Takayanagi R, Nawata H 2001 The subnudear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 276:28395-28401
22. van Steensel B, Brink M, van der Meulen K, van Binnendijk EP, Wansink DG, de Jong L, de Kloet ER, van Driel R 1995 Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J Cell Sci 108:3003-3011
23. McNally JG, Muller WG, Walker D, Wolford R, Hager GL 2000 The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262-1265
24. Nishi M, Ogawa H, Ito T, Matsuda KI, Kawata M 2001 Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants. Mol Endocrinol 15:1077-1092
25. Thiry M, Goessens G 1992 Where, within the nucleolus, are the rRNA genes located? Exp Cell Res 200:1-4
26. Scheer U, Hock R 1999 Structure and function of the nucleolus. Curr Opin Cell Biol 11:385-390
27. van Driel R, Wansink DG, van Steensel B, Grande MA, Schul W, de Jong L 1995 Nuclear domains and the nuclear matrix. Int Rev Cytol 162A:151-189.
28. Strouboulis J, Wolffe AP 1996 Functional compartmentalization of the nucleus. J Cell Sci 109:1991-2000
29. Lamond AI, Earnshaw WC 1998 Structure and function in the nucleus. Science 280:547-553
30. Nakamura H, Morita T, Sato C 1986 Structural organizations of replicon domains during DNA synthetic phase in the mammalian nucleus. Exp Cell Res 165:291-297
31. Nakayasu H, Berezney R 1989 Mapping replicational sites in the eucaryotic cell nucleus. J Cell Biol 108:1-11
32. Hozak P, Jackson DA, Cook PR 1994 Replication factories and nuclear bodies: the ultrastructural characterization of replication sites during the cell cycle. J Cell Sci 107:2191-2202
33. Jackson DA, Cook PR 1995 The structural basis of nuclear function. Int Rev Cytol 162A:125-149
34. Qumsiyeh MB 1999 Structure and function of the nucleus: anatomy and physiology of chromatin. Cell Mol Life Sci 55:1129-1140
35. Brown K 1999 Nuclear structure, gene expression and development. Crit Rev Eukaryot Gene Expr 9:203-212
36. Guo A, Salomoni P, Luo J, Shin A, Zhong S, Gu W, Paolo Pandolfi P 2000 The function of PML in p53-dependent apoptosis. Nat Cell Biol 2:730-736
37. Baumann CT, Ma H, Wolford R, Reyes JC, Maruvada P, Lim C, Yen PM, Stallcup MR, Hager GL 2001 The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol 15:485-500
38. Mote PA, Leary JA, Clarke CL 1998 Immunohistochemical detection of progesterone receptors in archival breast cancer. Biotech Histochem 73:117-127
39. Clarke CL, Zaino RJ, Feil PD, Miller JV, Steck ME, Ohlsson-Wilhelm BM, Satyaswaroop PG 1987 Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 121:1123-1132
40. Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL 2001 Detection of progesterone receptor forms A and B by immunohistochemical analysis. J Clin Pathol 54:624-630
41. Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E 1996 The Ernst Schering Poster Award. Intracellular traffic of steroid hormone receptors. J Steroid Biochem Mol Biol 56:3-9
42. Thorneycroft IH, Mishell Jr DR, Stone SC, Kharma KM, Nakamura RM 1971 The relation of serum 17-hydroxyprogesterone and estradiol-17-β levels during the human menstrual cycle. Am J Obstet Gynecol 111:947-951
43. Htun H, Barsony J, Renyi I, Gould DL, Hager GL 1996 Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc Natl Acad Sci USA 93:4845-4850
44. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A 1998 Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 95:2973-2978
45. Racz A, Barsony J 1999 Hormone-dependent translocation of vitamin D receptors is linked to transactivation. J Biol Chem 274:19352-19360
46. Prufer K, Racz A, Lin GC, Barsony J 2000 Dimerization with retinoid X receptors promotes nuclear localization and subnudear targeting of vitamin D receptors. J Biol Chem 275:41114-41123
47. Clarke CL, Sutherland RL 1990 Progestin regulation of cellular proliferation. Endocr Rev 11:266-301
48. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218
49. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB 1993 Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256-1265
50. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP 1993 Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
51. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB 1994 A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8:1347-1360
52. Ferenczy A, Bertrand G, Gelfand MM 1979 Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 133:859-867
53. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM 2000 Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751-1754
54. Wen DX, Xu Y, Mais DE, Goldman ME, McDonnell DP 1994 The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14:8356-8364
55. McDonnell DF, Goldman ME 1994 RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem 269:11945-11949
56. Kraus WL, Weis KE, Katzenellenbogen BS1995 Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist-and antagonist-occupied progestin receptors. Mol Cell Biol 15:1847-1857
57. Mulac-Jericevic B, Lydon JP, DeMayo F, Conneely OM 2003 Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100:9744-9749
58. Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G 1991 Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J Steroid Biochem Mol Biol 38:285-291
59. Gronemeyer H 1991 Transcription activation by estrogen and progesterone receptors. Annu Rev Genet 25:89-123
60. DeMarzo AM, Beck CA, Onate SA, Edwards DP 1991 Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. Proc Natl Acad Sci USA 88:72-76
61. Mohamed MK, Tung L, Takimoto GS, Horwitz KB 1994 The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer. J Steroid Biochem Mol Biol 51:241-250
62. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA 1997 Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11:1486-1496
63. Matsuda KI, Ochiai I, Nishi M, Kawata M 2002 Colocalization and ligand-dependent discrete distribution of the estrogen receptor (ER)α and ER β. Mol Endocrinol 16:2215-2230
64. Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, Roy AK 2000 Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol 14:1162-1174
65. Karvonen U, Janne OA, Palvimo JJ 2002 Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. FEBS Lett 523:43-47
66. Grande MA, van der Kraan I, de Jong L, van Driel R 1997 Nuclear distribution of transcription factors in relation to sites of transcription and RNA polymerase II. J Cell Sci 110:1781-1791
67. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198
68. Thijssen JH, Blankenstein MA 1989 Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. Eur J Cancer Clin Oncol 25:1953-1959
69. Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, Gentleman R, Gullans SR, Wei LJ, Wilcox M 2001 Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 83:177-185